Skip to content

Randomized controlled trials of acupuncture treatment for ischemia with non-obstructive coronary artery disease as well as studies on its effects on exercise tolerance improvement

Randomized controlled trials of acupuncture treatment for ischemia with non-obstructive coronary artery disease as well as studies on its effects on exercise tolerance improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000454
Enrollment
Unknown
Registered
2024-09-19
Start date
2024-09-20
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INOCA

Interventions

Treatment group:On the basis of conventional treatment with western medicine (aspirin/Clopidogrel/Ticagrelor + ß-receptor blocker +ACEI/ARB/ARNI+ statins) the treatment group was acupuncture Tongli/Ne
Control group:On the basis of conventional treatment with western medicine (aspirin/clopidogrel/ticagrelor+ß-receptor blocker+ACEI/ARB/RNI+statins), the control group received sham acupuncture at Tong

Sponsors

The Third Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Coronary angiography/coronary CT stenosis <50%;(2) Angina pectoris grading criteria according to the Canadian Cardiovascular Society angina severity grading is divided into I II III;(3) Age 30~70 years old male and female;(4) Sign informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiovascular diseases such as severe cardiopulmonary insufficiency and severe arrhythmia;(2) Patients with severe cerebrovascular diseases of the liver kidney or blood system or malignant tumors;(3) Pregnant or lactating women or those who have fertility requirements in the past six months;(4) Combined with mental illness or unwilling to cooperate;(5) Participants who have participated in or are participating in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
SAQ;

Secondary

MeasureTime frame
VAS;Frequency of angina attacks;CPET;ECG;

Countries

CHINA

Contacts

Public ContactWang yanxin

The Third Affiliated Hospital of Changchun University of Chinese Medicine

wyanxin2000@126.com133 6431 0130

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026